Honluten is a peptide complex containing amino acids that contribute to the normalization of lung and bronchial mucosa function and cells.
Honluten has been clinically studied for its effectiveness in the complex prevention and treatment of patients with lung and bronchial dysfunction in acute and chronic respiratory diseases of infectious and non-infectious origin, as well as for maintaining respiratory function in elderly and elderly people.
We found that a course of administration of Honluten in addition to the means of conventional therapy in patients with respiratory failure and lung affection contributed to the improvement of health, reduction of frequency of coughing and choking attacks, reduction of sputum volume, increase of physical performance. We registered positive dynamics in the form of a decrease of the number of rales and of the amount of secreted sputum, which reflected the general tendency of the decrease of inflammatory manifestations of the disease.
Recommended:
– Chronic respiratory failure
– Chronic cardiopulmonary insufficiency
– After pneumonia
– Consequences of prolonged artificial ventilation
– Pulmonary tuberculosis in remission
– Chest injuries
– Burns of upper airways
– Chronic respiratory failure
– Consequences of pneumonia.Br>- Consequences of toxic pulmonary injuries including carbon monoxide poisoning
– Intense sporting activities
– To support respiratory system in elderly and very old people
Composition of the product
Peptide complex AC-7-(glycine, glutamic acid, asparagic acid).
Auxiliary substances: microcrystalline cellulose (E460), beet sugar, lactose, starch, tween-80. As an additional source of peptides.
Method of use
Adults: 1-2 capsules 1-2 times a day with meals. The duration of intake of 10-30 days. The second course should be repeated in 4-6 months.
Brand form: 20 capsules of 0.2 g
.
Weight | 0.065 kg |
---|
Related products
Buy Honluten N60 – lung peptides with delivery to USA, UK, Europe and over 120 other countries.